Hormonal Predictors of Oncologic Surgery

Hypogonadism Clinical Trial

— HPOS  

Official title:

The Association of Hypogonadism and Post-operative Outcomes of Oncologic Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02471157
• Other study ID #: 1408015434
• Status: Completed
• Start date: January 2015
• Est. completion date: October 2016

Study information

• Verified date: January 2019
• Source: Weill Medical College of Cornell University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

An observational trial to determine whether preoperative hormonal status predicts outcomes of oncologic surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: October 2016
• Est. primary completion date: October 2016
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Undergoing above surgery for cancer

Exclusion Criteria:

• Started hormonal replacement in past two months

Related Conditions & MeSH terms

• Hypogonadism

Intervention

Other:
• Observation

Locations

Country	Name	City	State
United States	Weill Cornell Medical College	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Weill Medical College of Cornell University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Length of Stay	Length of post-operative stay	6 days, on average
Primary	Complication rate, post-operative	Complication rate during initial postoperative period	6 days, on average
Primary	Complication rate, 30 day	Complication rate during the initial 30 days after surgery	30 days
Primary	Complication rate, 90 days	Complication rate during the initial 90 days after surgery	90 days